The Food and Drug Administration will accept public input by Feb. 27 on recommendations by the World Health Organization to impose international manufacturing and distribution restrictions, under international treaties, on certain drug substances. Any comments will be considered in preparing the U.S. position on these proposals for a meeting of the United Nations Commission on Narcotic Drugs  in Vienna, Austria, in March.

Specifically, the WHO is recommending the addition of four substances to Schedules II or IV of the 1971 Convention on Psychotropic Substances: 3-chloromethcathinone or 3-CMC; dipentylone; 2-fluorodeschloroketamine; and bromazolam. Butonitazene would also be added to Schedule I of the 1961 Single Convention on Narcotic Drugs. Furthermore, the performance of a critical review has been recommended for carisoprodol, while flubromazepam and nitrous oxide would be kept under surveillance.

Copyright © 2024 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.

ST&R: International Trade Law & Policy

Since 1977, we have set the standard for international trade lawyers and consultants, providing comprehensive and effective customs, import and export services to clients worldwide.

View Our Services 


Cookie Consent

We have updated our Privacy Policy relating to our use of cookies on our website and the sharing of information. By continuing to use our website or subscribe to our publications, you agree to the Privacy Policy and Terms & Conditions.